[Fluoroscopic-Guided Primary Single-Step Percutaneous Gastrostomy: Initial Results Using the Freka® GastroTube.]

Standard

[Fluoroscopic-Guided Primary Single-Step Percutaneous Gastrostomy: Initial Results Using the Freka® GastroTube.]. / Busch, Jasmin Desiree; Schönnagel, Björn; Schröter, Christiane; Herrmann, Jochen; Bannas, Peter; Koops, Andreas; Adam, Gerhard; Habermann, Christian.

in: ROFO-FORTSCHR RONTG, Jahrgang 183, Nr. 7, 7, 2011, S. 641-644.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{98e629a3cce24273bdd1527368b965a3,
title = "[Fluoroscopic-Guided Primary Single-Step Percutaneous Gastrostomy: Initial Results Using the Freka{\textregistered} GastroTube.]",
abstract = "PURPOSE: To determine the practicability and outcome of fluoroscopic-guided primary one-step treatment of percutaneous gastrostomy (PG) with the system Freka{\textregistered} Gastro Tube (Fresenius Kabi, Germany). MATERIALS AND METHODS: In 39 patients (mean age 62.7 ± 12.0 years), primary PG was performed based on clinical indication from August 2009 to April 2010. The intervention was performed by an experienced radiologist under aseptic conditions by direct puncture with Freka{\textregistered} Gastro Tube under fluoroscopic guidance. The clinical data and outcome as well as any complications originated from the electronic archive of the University Medical Center Hamburg-Eppendorf. RESULTS: The intervention was technically successful in all 39 patients. Within the mean follow-up time of 155.3 ± 73.6 days, 29 patients (74.4 %) did not experience complications. 10 patients (25.6 %) had to be revised. Complications manifested after a mean of 135.6 ± 61.2 days and mainly corresponded to accidental dislocation (50 %). One patient had to be surgically revised under suspicion of a malpositioned tube and suspected intestinal perforation. Clinically relevant wound infections were not detected. The total costs per patient were 553.17 for our single-step treatment (OPS 5 - 431.x) vs. 963.69 (OPS 5 - 431.x and OPS 8 - 123.0) for the recommended two-step treatment. CONCLUSION: Fluoroscopic-guided primary single-step treatment with Freka{\textregistered} Gastro Tube system is feasible and not associated with an increased complication rate when compared to published literature applying a two-step treatment approach. Material costs as well as human and time resources could be significantly reduced using the single-step treatment.",
author = "Busch, {Jasmin Desiree} and Bj{\"o}rn Sch{\"o}nnagel and Christiane Schr{\"o}ter and Jochen Herrmann and Peter Bannas and Andreas Koops and Gerhard Adam and Christian Habermann",
year = "2011",
language = "Deutsch",
volume = "183",
pages = "641--644",
journal = "ROFO-FORTSCHR RONTG",
issn = "1438-9029",
publisher = "Georg Thieme Verlag KG",
number = "7",

}

RIS

TY - JOUR

T1 - [Fluoroscopic-Guided Primary Single-Step Percutaneous Gastrostomy: Initial Results Using the Freka® GastroTube.]

AU - Busch, Jasmin Desiree

AU - Schönnagel, Björn

AU - Schröter, Christiane

AU - Herrmann, Jochen

AU - Bannas, Peter

AU - Koops, Andreas

AU - Adam, Gerhard

AU - Habermann, Christian

PY - 2011

Y1 - 2011

N2 - PURPOSE: To determine the practicability and outcome of fluoroscopic-guided primary one-step treatment of percutaneous gastrostomy (PG) with the system Freka® Gastro Tube (Fresenius Kabi, Germany). MATERIALS AND METHODS: In 39 patients (mean age 62.7 ± 12.0 years), primary PG was performed based on clinical indication from August 2009 to April 2010. The intervention was performed by an experienced radiologist under aseptic conditions by direct puncture with Freka® Gastro Tube under fluoroscopic guidance. The clinical data and outcome as well as any complications originated from the electronic archive of the University Medical Center Hamburg-Eppendorf. RESULTS: The intervention was technically successful in all 39 patients. Within the mean follow-up time of 155.3 ± 73.6 days, 29 patients (74.4 %) did not experience complications. 10 patients (25.6 %) had to be revised. Complications manifested after a mean of 135.6 ± 61.2 days and mainly corresponded to accidental dislocation (50 %). One patient had to be surgically revised under suspicion of a malpositioned tube and suspected intestinal perforation. Clinically relevant wound infections were not detected. The total costs per patient were 553.17 for our single-step treatment (OPS 5 - 431.x) vs. 963.69 (OPS 5 - 431.x and OPS 8 - 123.0) for the recommended two-step treatment. CONCLUSION: Fluoroscopic-guided primary single-step treatment with Freka® Gastro Tube system is feasible and not associated with an increased complication rate when compared to published literature applying a two-step treatment approach. Material costs as well as human and time resources could be significantly reduced using the single-step treatment.

AB - PURPOSE: To determine the practicability and outcome of fluoroscopic-guided primary one-step treatment of percutaneous gastrostomy (PG) with the system Freka® Gastro Tube (Fresenius Kabi, Germany). MATERIALS AND METHODS: In 39 patients (mean age 62.7 ± 12.0 years), primary PG was performed based on clinical indication from August 2009 to April 2010. The intervention was performed by an experienced radiologist under aseptic conditions by direct puncture with Freka® Gastro Tube under fluoroscopic guidance. The clinical data and outcome as well as any complications originated from the electronic archive of the University Medical Center Hamburg-Eppendorf. RESULTS: The intervention was technically successful in all 39 patients. Within the mean follow-up time of 155.3 ± 73.6 days, 29 patients (74.4 %) did not experience complications. 10 patients (25.6 %) had to be revised. Complications manifested after a mean of 135.6 ± 61.2 days and mainly corresponded to accidental dislocation (50 %). One patient had to be surgically revised under suspicion of a malpositioned tube and suspected intestinal perforation. Clinically relevant wound infections were not detected. The total costs per patient were 553.17 for our single-step treatment (OPS 5 - 431.x) vs. 963.69 (OPS 5 - 431.x and OPS 8 - 123.0) for the recommended two-step treatment. CONCLUSION: Fluoroscopic-guided primary single-step treatment with Freka® Gastro Tube system is feasible and not associated with an increased complication rate when compared to published literature applying a two-step treatment approach. Material costs as well as human and time resources could be significantly reduced using the single-step treatment.

M3 - SCORING: Zeitschriftenaufsatz

VL - 183

SP - 641

EP - 644

JO - ROFO-FORTSCHR RONTG

JF - ROFO-FORTSCHR RONTG

SN - 1438-9029

IS - 7

M1 - 7

ER -